Showing 1 - 20 results of 114 for search '"Pramipexol"', query time: 0.08s Refine Results
  1. 1
  2. 2

    Sustained-release pramipexole in the treatment of Parkinson’s disease by Natalia Vladimirovna Fedorova

    Published 2012-03-01
    Subjects: “…immediate- and extended-release pramipexole…”
    Get full text
    Article
  3. 3
  4. 4
  5. 5

    Pramipexole enhances reward learning by preserving value estimates by Halahakoon, DC, Kaltenboeck, A, Martens, M, Geddes, JG, Harmer, CJ, Cowen, P, Browning, M

    Published 2023
    “…This is a plausible mechanism for pramipexole’s antidepressant effect.</p>…”
    Journal article
  6. 6

    Effects of pramipexole on the processing of rewarding and aversive taste stimuli by McCabe, C, Harwood, J, Brouwer, S, Harmer, C, Cowen, P

    Published 2013
    “…Rationale: Pramipexole, a D2/D3 dopamine receptor agonist, has been implicated in the development of impulse control disorders in patients with Parkinson's disease. …”
    Journal article
  7. 7

    Effects of pramipexole on the processing of rewarding and aversive taste stimuli. by Mccabe, C, Harwood, J, Brouwer, S, Harmer, C, Cowen, P

    Published 2013
    “…RATIONALE: Pramipexole, a D2/D3 dopamine receptor agonist, has been implicated in the development of impulse control disorders in patients with Parkinson's disease. …”
    Journal article
  8. 8

    Solid Microneedles for Transdermal Delivery of Amantadine Hydrochloride and Pramipexole Dihydrochloride by Mylien T. Hoang, Kevin B. Ita, Daniel A. Bair

    Published 2015-09-01
    “…The aim of this project was to study the influence of microneedles on transdermal delivery of amantadine hydrochloride and pramipexole dihydrochloride across porcine ear skin in vitro. …”
    Get full text
    Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Structure Identification and Risk Assurance of Unknown Impurities in Pramipexole Oral Drug Formulation by Raymond R. Tjandrawinata, Antonius H. Cahyana, Ajeng O. Nugroho, Indra K. Adi, Joseph S. R. Talpaneni

    Published 2024-01-01
    “…The binding energy result showed that pramipexole interaction with dopamine receptors D2 and D3 was higher than pramipexole mannose adduct and pramipexole ribose adduct.…”
    Get full text
    Article
  18. 18

    The Use of Pramipexole to Treat Persistent Genital Arousal Disorder: A Case Report by Becky Kaufman Lynn, MD, MBA, Chloe Grabenhorst, MS, Barry R. Komisaruk, PhD, Irwin Goldstein, MD, Jim Pfaus, PhD

    Published 2021-08-01
    Subjects: “…Persistent genital arousal disorder, Restless genital syndrome, Pramipexole, Dopamine…”
    Get full text
    Article
  19. 19
  20. 20

    Premorbid performances determine the deleterious effects of nigrostriatal degeneration and pramipexole on behavioural flexibility by Mélina Decourt, Eric Balado, Maureen Francheteau, Marcello Solinas, Marianne Benoît-Marand, Pierre-Olivier Fernagut

    Published 2023-03-01
    “…Pramipexole induced a decrease of behavioral flexibility that was exacerbated in lesioned rats and in the most flexible individuals. …”
    Get full text
    Article